Secukinumab Shows Benefit for Hidradenitis Suppurativa at 1 Year
Currently, the tumor necrosis factor inhibitor adalimumab is the only biologic therapy approved for the treatment of moderate to severe hidradenitis suppurativa.
Stay updated with breaking news from Watch Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Currently, the tumor necrosis factor inhibitor adalimumab is the only biologic therapy approved for the treatment of moderate to severe hidradenitis suppurativa.
Many busy physicians use dating apps to find romance – some specifically designed for doctors. But putting "MD" on a dating profile can bring mixed results.
A polypill that targets vascular risk factors can help slow functional but not cognitive decline compared with placebo in older relatively healthy adults, new research suggests.
The population-based cohort study, using electronic medical record data, also evaluated the association of inflammatory bowel disease with oral tetracyclines and with acne itself.
The drug overdose death rate in the United States climbed nearly 400% from 2001 to 2021, with much of the increase occurring in the last 2 years, the National Center for Heath Statistics reports.